fda warning letters glp-1 compounding september 2025 Beyond the Headlines: to Compounders The FDA Just Sent 25
Description
Each GLP-1 has a specific shelf life after the first use
Liraglutide (Victoza for diabetes, Saxenda for weight management) is administered as a daily subcutaneous injection
The company's quick withdrawal of its compounded GLP-1 pill, just days after its launch, signals a recognition of the escalating legal and regulatory pressure
Many plans do not cover GLP-1 drugs for weight loss
